Contradictory Effects of β1- and α1- Aderenergic Receptor Blockers on Cardio-Ankle Vascular Stiffness Index (CAVI)
- 1 January 2011
- journal article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 18 (1), 49-55
- https://doi.org/10.5551/jat.3582
Abstract
The cardio-ankle vascular stiffness index (CAVI) is a new parameter that reflects the stiffness of the aorta, femoral artery and tibial artery as a whole. One of its conspicuous features is that CAVI is independent of blood pressure at measuring time, theoretically. But, it has not been experimentally proved yet. For confirmation, pharmacological studies were performed comparing with brachial-ankle pulse wave velocity (baPWV). Used drugs were a β1-adrenoceptor blocker, metoprorol and an α1- adrenoceptor blocker doxazosin. Both were administered to 12 healthy volunteer men. CAVI and baPWV were measured every one hour for 6 hours using VaSera. When metoprolol (80 mg) was administered to 12 healthy volunteer men, systolic blood pressure decreased from 131.4 ± 4.5 to 118.3 ± 4.1 mmHg (mean ± SE) (p < 0.05) at the 3rd hour, and diastolic blood pressure decreased from 85.3 ± 4.0 to 75.3 ± 3.0 mm Hg (p < 0.05). baP-WV decreased from 13.93 ± 0.46 to 12.46 ± 0.49 m/sec (p < 0.05), significantly, but CAVI did not change (8.16 ± 0.29 to 8.24 ± 0.27) (p = 0.449). ΔbaPWV at each time was significantly correlated with both Δsystolic and Δdiastolic blood pressures, but ΔCAVI was not correlated with either Δblood pressure. When doxazosin (4 mg) was administered to the same men, systolic blood pressure decreased from 130.2 ± 4.6 to 117.2 ± 4.8 mmHg (p < 0.05) at the 3rd hour. Diastolic blood pressure also decreased from 85.1 ± 4.1 to 74.2 ± 3.9 mmHg (p < 0.05). baPWV decreased from 13.98 ± 0.68 to 12.25 ± 0.53 m/sec (p < 0.05), significantly. CAVI also decreased from 8.15 ± 0.28 to 7.18 ± 0.37 (p < 0.05), significantly. These results suggested that CAVI was not affected by blood pressure at the measuring time directly, but affected by the changes of contractility of smooth muscle cells.Keywords
This publication has 28 references indexed in Scilit:
- Usefulness of brachial-ankle pulse wave velocity as a predictive marker of multiple coronary artery occlusive disease in Korean type 2 diabetes patientsDiabetes Research and Clinical Practice, 2009
- Clinical Significance and Reproducibility of New Arterial Distensibility IndexCirculation Journal, 2007
- A Novel Blood Pressure-independent Arterial Wall Stiffness Parameter; Cardio-Ankle Vascular Index (CAVI)Journal of Atherosclerosis and Thrombosis, 2006
- Validity, Reproducibility, and Clinical Significance of Noninvasive Brachial-Ankle Pulse Wave Velocity Measurement.Hypertension Research, 2002
- Aortic Pulse Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive PatientsHypertension, 1999
- Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients—2-year trialCardiovascular Drugs and Therapy, 1990
- Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in JapanAtherosclerosis, 1988
- THE EFFECT OF BLOOD PRESSURE ALTERATION ON THE PULSE WAVE VELOCITYHeart, 1964
- ARTERIAL ELASTICITY IN MAN IN RELATION TO AGE AS EVALUATED BY THE PULSE WAVE VELOCITY METHODArchives of Internal Medicine, 1934
- The velocity of pulse wave in manProceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character, 1922